HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ocular manifestations of chronic graft-versus-host disease in patients treated with extracorporeal photochemotherapy.

AbstractPURPOSE:
Eye involvement has long been appreciated in patients with chronic graft versus host disease (cGVHD). In particular, ocular complications are frequent and can be potentially severe in patients with steroid-refractory cGVHD, and therefore necessitate close monitoring. This prospective study was designed to describe eye manifestations of cGVHD in a large series of patients monitoring them before and after 1 year of extracorporeal photochemotherapy (ECP). ECP is a relatively new therapeutic approach based on the biological effects of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet A light (UVA) on mononuclear cells collected by apheresis, and reinfused into the patient.
METHODS:
Only patients with steroid-refractory cGVHD under treatment with ECP, who developed cGVHD-related eye symptoms, were selected for the study. Ophthalmologic examination was repeated every 3 months. Only patients with complete recovery of the ocular manifestations and symptoms were considered responsive.
RESULTS:
In our study we observed eye alterations in 24 out of 140 patients (17%) with cGVHD. After 12 months of ECP, 10 out of 21 patients (48%) completely responded to the therapy. In all these cases the contribution of ECP was also essential in all the other organs subject to cGVHD.
CONCLUSIONS:
Further studies are necessary to clarify the role of ECP in patients with cGVHD, especially in associated eye manifestations. Although our experience is limited, it suggests that ECP could be a safe and effective therapy for steroid-refractory eye manifestations of cGVHD.
AuthorsE Motolese, P Rubegni, S Poggiali, P A Motolese, G Marotta, L Russo, G D'Ascenzo, M R Carcagni, M Fruschelli, I Motolese, M Fimiani
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) 2007 Nov-Dec Vol. 17 Issue 6 Pg. 961-9 ISSN: 1120-6721 [Print] United States
PMID18050124 (Publication Type: Journal Article)
Chemical References
  • Methoxsalen
Topics
  • Adolescent
  • Adult
  • Chronic Disease
  • Eye Diseases (etiology, therapy)
  • Female
  • Graft vs Host Disease (etiology, therapy)
  • Hematologic Diseases (therapy)
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Male
  • Methoxsalen (therapeutic use)
  • Middle Aged
  • Photopheresis (methods)
  • Prospective Studies
  • Transplantation, Homologous
  • Ultraviolet Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: